You're reading the free version. Trader adds the live tape and alerts.
Start tracking
DFTX Award Disclosure
Krebs Andreas · SEC Form 4 · Filed Jun 15, 2026
Award
Calculated transaction value
$0
Krebs Andreas Director
DFTX
Transaction date
Jun 11, 2026
Public filing date
Jun 15, 2026
Filing lag
Filed 4 days later
DFTX daily price context
Close on/before transaction
$24.11
Jun 11, 2026
First close after public filing
$24.16
Jun 16, 2026
30-day return after filing
+88.99%
Through Jul 15, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Shares
- Quantity / price
- 4,666 shares @ $0
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0001193125-26-271157
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Definium Therapeutics, Inc. DFTX Current | Award | Jun 11, 2026 | $0 |
| Definium Therapeutics, Inc. DFTX | Award | Jun 11, 2026 | $0 |